Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Burotto

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Cancer|April 24, 2015
Emphasizing unique strengths and eliminating redundancy for research in low-income and middle-income countries: Lessons from a South American countryMauricio Burotto, Vinay Prasad
Annals of Translational Medicine|October 29, 2019
Nephrectomy in metastatic renal cell carcinoma with venous thrombus: more thrombus equals less benefit?Mauricio Burotto, Alex Renner
Oral Oncology|January 18, 2014
PPARγ in head and neck cancer preventionMauricio Burotto, Eva Szabo
Expert Opinion on Biological Therapy|July 11, 2017
MABp1 for the treatment of colorectal cancerGeraldine O'Sullivan Coyne, Mauricio Burotto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Pseudoprogression and Immune-Related Response in Solid TumorsVictoria L Chiou, Mauricio Burotto
Expert Opinion on Therapeutic Targets|February 29, 2024
Considerations on the implementation of MAP4K4 inhibitors as cancer treatmentJaime Gonzalez-Montero, Mauricio Burotto
Expert Opinion on Biological Therapy|July 15, 2014
Clinical experience with ramucirumab : outcomes in breast cancerGeraldine O'Sullivan Coyne, Mauricio Burotto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Reply to A. Wong et alVictoria L Chiou, Mauricio Burotto
The Oncologist|November 13, 2013
Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?Mauricio Burotto, Antonio Tito Fojo
Expert Review of Hematology|May 12, 2016
Double hit lymphoma: from biology to therapeutic implicationsMauricio Burotto, Alejandro Berkovits, Kieron Dunleavy
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Cancer|April 24, 2015
Emphasizing unique strengths and eliminating redundancy for research in low-income and middle-income countries: Lessons from a South American countryMauricio Burotto, Vinay Prasad
Annals of Translational Medicine|October 29, 2019
Nephrectomy in metastatic renal cell carcinoma with venous thrombus: more thrombus equals less benefit?Mauricio Burotto, Alex Renner
Oral Oncology|January 18, 2014
PPARγ in head and neck cancer preventionMauricio Burotto, Eva Szabo
Expert Opinion on Biological Therapy|July 11, 2017
MABp1 for the treatment of colorectal cancerGeraldine O'Sullivan Coyne, Mauricio Burotto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Pseudoprogression and Immune-Related Response in Solid TumorsVictoria L Chiou, Mauricio Burotto
Expert Opinion on Therapeutic Targets|February 29, 2024
Considerations on the implementation of MAP4K4 inhibitors as cancer treatmentJaime Gonzalez-Montero, Mauricio Burotto
Expert Opinion on Biological Therapy|July 15, 2014
Clinical experience with ramucirumab : outcomes in breast cancerGeraldine O'Sullivan Coyne, Mauricio Burotto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Reply to A. Wong et alVictoria L Chiou, Mauricio Burotto
The Oncologist|November 13, 2013
Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?Mauricio Burotto, Antonio Tito Fojo
Expert Review of Hematology|May 12, 2016
Double hit lymphoma: from biology to therapeutic implicationsMauricio Burotto, Alejandro Berkovits, Kieron Dunleavy
Pageof 9